Strauss Group Ltd.
Strauss Group Ltd. (SGLJF) Financial Performance & Income Statement Overview
Analyze Strauss Group Ltd. (SGLJF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Strauss Group Ltd. (SGLJF) Income Statement & Financial Overview
View the income breakdown for Strauss Group Ltd. SGLJF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.89B | $1.79B | $1.87B | $1.70B |
| Cost of Revenue | $1.27B | $1.20B | $1.22B | $1.12B |
| Gross Profit | $612.00M | $587.00M | $653.00M | $583.00M |
| Gross Profit Ratio | $0.32 | $0.33 | $0.35 | $0.34 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $461.00M | -$811.00M | $487.00M | $473.00M |
| Operating Expenses | $431.00M | $35.00M | $437.00M | $445.00M |
| Total Costs & Expenses | $1.71B | $1.24B | $1.66B | $1.56B |
| Interest Income | $29.00M | -$14.00M | $5.00M | $24.00M |
| Interest Expense | $42.00M | $44.00M | $45.00M | $40.00M |
| Depreciation & Amortization | $88.00M | $67.00M | $90.00M | $89.00M |
| EBITDA | $298.00M | $698.00M | $292.00M | $251.00M |
| EBITDA Ratio | $0.16 | $0.39 | $0.16 | $0.15 |
| Operating Income | $181.00M | $552.00M | $216.00M | $138.00M |
| Operating Income Ratio | $0.10 | $0.31 | $0.12 | $0.08 |
| Other Income/Expenses (Net) | -$13.00M | $35.00M | -$59.00M | -$16.00M |
| Income Before Tax | $168.00M | $587.00M | $157.00M | $122.00M |
| Income Before Tax Ratio | $0.09 | $0.33 | $0.08 | $0.07 |
| Income Tax Expense | $57.00M | $169.00M | $36.00M | $21.00M |
| Net Income | $86.00M | $392.00M | $99.00M | $82.00M |
| Net Income Ratio | $0.05 | $0.22 | $0.05 | $0.05 |
| EPS | $0.74 | $3.36 | $0.85 | $0.70 |
| Diluted EPS | $0.74 | $3.36 | $0.85 | $0.70 |
| Weighted Avg Shares Outstanding | $116.22M | $116.50M | $116.47M | $117.14M |
| Weighted Avg Shares Outstanding (Diluted) | $116.22M | $116.50M | $116.47M | $117.14M |
Over the past four quarters, Strauss Group Ltd. demonstrated steady revenue growth, increasing from $1.70B in Q2 2024 to $1.89B in Q1 2025. Operating income reached $181.00M in Q1 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $298.00M, reflecting operational efficiency. Net income dropped to $86.00M, with EPS at $0.74. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan